PHARMACYTE BIOTECH INC
PMCB·71715X203·US·Common Stock·Healthcare - Biotechnology-13D/G
PMCB (PHARMACYTE BIOTECH INC) is held by 19 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($218,203), GEODE CAPITAL MANAGEMENT, LLC ($95,681), VANGUARD CAPITAL MANAGEMENT LLC ($43,719). Net institutional sentiment: Mixed.
19
Holders
$565,327
Total Value
39% (18)
Consensus
7 buying - 11 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Jan 7, 2026 · Activists Feb 13, 2026 · Congress none
ActivistMPMitchell P. Kopin5.0%Feb 13, 2026
InsiderSJSCHECHTER JONATHANBuy $17KJan 7, 2026
InsiderSJSilverman JoshuaBuy $33KJan 7, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 22
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer